4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000114
Chief Legal Officer sold 9,870 shares at $25.01 ($246,843)
- Chief Legal Officer acquired 9,870 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,463 | $1.86 | $8,301 | 29,055 | D |
| 2024-08-26 | Exercise or conversion : show line 2 in the form 10b5-1 | +5,407 | $9.57 | $51,745 | 34,462 | D |
| 2024-08-26 | Sale : show line 3 in the form 10b5-1 | −9,870 | $25.01 | $246,843 | 24,592 | D |
| Open-market sales · 9,870 sh · avg $25.01 · $246,843 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) | −4,463 | 5,537 | D |
| 2024-08-26 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −5,407 | 106,259 | D |
Loading xslF345X05/wk-form4_1724711007.xml…